Petmed Express PETS

Petmed Express reported Q2 2027 results

Petmed Express (PETS) filed an 8-K with the SEC on Nov 10, 2026, 4:18 pm ET. Source: the filing on SEC EDGAR.

Item 2.02 Reports results

Form
8-K
Filed
Importance
Major
  1. Net sales were $35.8 million, down 19.4% from $44.4 million
  2. Net loss was $6.4 million, or $0.31 per share, compared to $8.5 million, or $0.41 per share
  3. Adjusted EBITDA was $(3.6) million, compared to $(2.3) million

Written from the 8-K on EDGAR. AI can make mistakes. Check the filing.

Get an email when Petmed Express files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Data on this page was fetched . The filing on SEC.gov is the record.